Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
children
|
| gptkbp:alternativeTo |
gptkb:inactivated_polio_vaccine_(IPV)
|
| gptkbp:cause |
vaccine-derived poliovirus
|
| gptkbp:contains |
live attenuated poliovirus
|
| gptkbp:contributedTo |
global polio eradication
|
| gptkbp:developedBy |
gptkb:Albert_Sabin
|
| gptkbp:effect |
high
|
| gptkbp:form |
gptkb:water
|
| gptkbp:globalPresence |
widespread
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oral polio vaccine (OPV)
|
| gptkbp:introducedIn |
1961
|
| gptkbp:notRecommendedFor |
immunocompromised individuals
|
| gptkbp:primaryImmunizationSchedule |
multiple doses
|
| gptkbp:recommendation |
gptkb:World_Health_Organization
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
mild gastrointestinal symptoms
rare paralysis |
| gptkbp:storage |
refrigerated
|
| gptkbp:type |
bivalent
monovalent trivalent |
| gptkbp:usedFor |
prevention of poliomyelitis
|
| gptkbp:WHOStatus |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:Polio_Vaccine
|
| gptkbp:bfsLayer |
6
|